# Johnson & Johnson MedTech acquires Laminar for $400M

Johnson & Johnson MedTech made an upfront payment of $400 million to acquire Laminar, a developer of a heart implant to reduce stroke risk. The deal includes additional milestone payments, and Laminar will join J&J's Biosense Webster division.

- Type: Acquisition
- Announced: 2023-11-30
- Where: United States
- Value: $400.0M
- Status: completed
- Products: left atrial appendage closure device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Johnson & Johnson](https://endata.com/companies/9845.md) (acquirer)
- [Laminar](https://endata.com/companies/74136.md) (target)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/johnson-johnson-medtech-acquires-heart-implant-company-laminar-for-400m/), 2023-12-01: "Johnson & Johnson (J&J) MedTech has made an upfront payment of $400m to acquire the privately held company Laminar, a US-based developer of a heart implant that reduces the chance of stroke."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.